Pharmacyclics' P2P Acquisition

Pharmacyclics raised a round of funding on March 05, 2015. Investors include AbbVie.

Pharmacyclics aims to build a viable biopharmaceutical company that develops and commercializes novel therapies intended to improve quality of life, increase duration of life, and resolve serious medi…

Articles about Pharmacyclics' P2P Acquisition: